Surrogate Markers of Effective Anti-Tumor Immunity

Abstract

Clinically effective cancer immunotherapy has been a long-term objective of many investigators. The identification and cloning of a number of tumor associated and tumor specific antigens directly address the fact that human cancer cells do express antigens. Recent clinical developments, such as the demonstrated anti-tumor activity of specific monoclonal… (More)
DOI: 10.1007/s10434-001-0190-6

Topics

  • Presentations referencing similar topics